Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Valavaara

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Breast Cancer Research and Treatment|August 1, 1990
Phase II trials with toremifene in advanced breast cancer: a reviewR Valavaara
Oncology (Williston Park, N.Y.)|May 1, 1997
Reliability of estrogen receptors in predicting response to antiestrogensR Valavaara
Annals of Clinical Research|January 1, 1988
The significance of estrogen receptors in tamoxifen and toremifene therapyR Valavaara, L Kangas
Cancer|January 1, 1985
Renal complications of mitomycin C therapy with special reference to the total doseR Valavaara, E Nordman
Cancer|December 1, 1990
Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifeneR Valavaara, J Tuominen, R Johansson
Cancer Immunology, Immunotherapy : CII|January 1, 1990
The immunological status of breast cancer patients during treatment with a new antiestrogen, toremifeneR Valavaara, J Tuominen, A Toivanen
Breast Cancer Research and Treatment|January 1, 1994
High dose toremifene in advanced breast cancer resistant to or relapsed during tamoxifen treatmentS Pyrhönen, R Valavaara, J Vuorinen, et al.
Journal of Steroid Biochemistry|June 22, 1990
Pharmacokinetics of toremifeneM Anttila, R Valavaara, S Kivinen, et al.
Breast Cancer Research and Treatment|December 8, 2000
Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancerH Joensuu, K Holli, H Oksanen, et al.
European Urology|January 1, 1989
Single-stage salvage cystectomy: results and complications in 20 patientsM Nurmi, R Valavaara, P Puntala, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Breast Cancer Research and Treatment|August 1, 1990
Phase II trials with toremifene in advanced breast cancer: a reviewR Valavaara
Oncology (Williston Park, N.Y.)|May 1, 1997
Reliability of estrogen receptors in predicting response to antiestrogensR Valavaara
Annals of Clinical Research|January 1, 1988
The significance of estrogen receptors in tamoxifen and toremifene therapyR Valavaara, L Kangas
Cancer|January 1, 1985
Renal complications of mitomycin C therapy with special reference to the total doseR Valavaara, E Nordman
Cancer|December 1, 1990
Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifeneR Valavaara, J Tuominen, R Johansson
Cancer Immunology, Immunotherapy : CII|January 1, 1990
The immunological status of breast cancer patients during treatment with a new antiestrogen, toremifeneR Valavaara, J Tuominen, A Toivanen
Breast Cancer Research and Treatment|January 1, 1994
High dose toremifene in advanced breast cancer resistant to or relapsed during tamoxifen treatmentS Pyrhönen, R Valavaara, J Vuorinen, et al.
Journal of Steroid Biochemistry|June 22, 1990
Pharmacokinetics of toremifeneM Anttila, R Valavaara, S Kivinen, et al.
Breast Cancer Research and Treatment|December 8, 2000
Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancerH Joensuu, K Holli, H Oksanen, et al.
European Urology|January 1, 1989
Single-stage salvage cystectomy: results and complications in 20 patientsM Nurmi, R Valavaara, P Puntala, et al.
Pageof 3